Navigation Links
Science Foundation Arizona Partners with AZCERT for Safe Medicines Initiative
Date:10/28/2013

PHOENIX, Oct. 28, 2013 /PRNewswire/ -- Science Foundation Arizona (SFAz) is assisting AZCERT (Arizona Center for Education and Research on Therapeutics) with its launch of the CredibleMeds program, a safe medicines initiative. AZCERT's CredibleMeds program conducts research and provides tools and education for the public, health care providers and researchers to improve the safe use of medicines.

"SFAz is pleased to help launch AZCERT and the CredibleMeds program," said SFAz President and CEO William Harris. "Working with entities such as AZCERT allows SFAz to continue its mission of furthering science education, development and research in Arizona, and fostering successful commercial applications of the most advanced biomedical science."

AZCERT, founded by renowned physician-scientist, Raymond Woosley, M.D., Ph.D., provides access to web-based materials designed to reduce avoidable harm caused by medicines and drug interactions. To determine the relative risk of harm by medicines, AZCERT utilizes its unique scientific methodology, Adverse Drug Event Causality Analysis (ADECA™). Using ADECA's specific algorithms, AZCERT has identified 39 medicines that have a clear risk of causing heart arrhythmias and sudden death. An additional group of 86 medicines that have effects on the electrocardiogram is being closely monitored using ADECA.

"Science Foundation Arizona's sponsorship of this program will provide a vital element in launching AZCERT's research and educational partnerships," said Woosley. "By employing AZCERT's innovative ADECA technology for safe medication use, medical organizations, physicians and researchers worldwide will be able to provide improved healthcare".

Already seeing more than 70,000 unique visitors from more than 80 countries on its website each month, AZCERT's goal is to improve medical outcomes from medications and to become the world's most trusted source of information on the safe use of medicines.

"CredibleMeds is saving lives by providing reliable information on which medicines can cause life-threatening arrhythmias," said Dr. Christopher Newton-Cheh, cardiologist at Massachusetts General Hospital, scientist in the Broad Institute and member of the Scientific Advisory Board for CredibleMeds. "I personally use and frequently recommend the CredibleMeds.org website to my fellow cardiologists, as well as psychiatrists, infectious disease specialists and internists, and most importantly patients—who are their own best advocates for safe prescribing."

Visit www.sfaz.org or www.CredibleMeds.org or for more information. To make a donation to CredibleMeds visit http://www.sfaz.org/support.CONTACT:The Lavidge Company 480.998.2600Teri Morris x577tmorris@lavidge.comKissy BlackAZCERT, Inc.615.310.1894kblack@azcert.org


'/>"/>
SOURCE Science Foundation Arizona
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
2. AbbVie Named a Science Top Employer
3. Jeeven BioSciences, Inc. Announces the Release of its Neuro-X(TM) Serum Free and Xeno Free Tissue Culture Media
4. SeeThruEquity, LLC Initiates Coverage on Pressure BioSciences, Inc.
5. SRI International Completes Biosciences Facility Expansion in Shenandoah Valley, Virginia
6. Wireless Health 2013 Convenes Leaders in Health and Sciences to Foster Advanced Developments in Wireless Health
7. Neurocrine Biosciences Announces Conference Call And Webcast To Present Third Quarter 2013 Financial Results
8. Osteo Science Foundation to Support Scientific and Clinical Research in Oral and Maxillofacial Surgery
9. 3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
11. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):